New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Omnicell, Inc.
OMCL
Shape
US Flag

NASDAQ

2B

Medical - Healthcare Information Services

Next Earning date - 13 Feb 2025

2B

Medical - Healthcare Information Services

Next Earning date - 13 Feb 2025

48.46USD
Shape3.01 ( 6.62%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

19%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

13%

Quote Panel

Shape
Updated November 27, 2024
1W 9.98 % 1M 20.10 % 3M 7.35 % 1Y 40.16 %

Key Metrics

Shape
  • Market Cap

    2.24B


  • Shares Outstanding

    46.32M


  • Share in Float

    45.15M


  • Dividende

    0


  • Earning Date

    13 Feb 2025


  • Price Target

    48.46


  • Average Volume

    562223


  • Beta

    0.815


  • Range

    25.12-55.75


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.omnicell.com


  • Sector

    Healthcare


Fundamentals

Shape

33.92x

P/E Ratio

2.11x

P/S Ratio

1.82x

P/B Ratio

0.5

Debt/Equity

-1.7%

Net Margin

$-0.4

EPS

How OMCL compares to sector?

P/E Ratio

Relative Strength

Shape

OMCL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape312%

2025-Revenue

$1.81

Shape852%

2025-EPS

$114M

Shape1634%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Barclays

upgrade

Previous: Not converted

2024-08-02

Now: Equal-Weight

Piper Sandler

upgrade

Previous: Not converted

2023-11-02

Now: Overweight

Benchmark

upgrade

Previous: Not converted

2023-02-27

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-64%

0.33
vs 0.92

Q1.23

arrow
arrow

-53%

0.39
vs 0.83

Q2.23

arrow
arrow

-32%

0.57
vs 0.84

Q3.23

arrow
arrow

-38%

0.62
vs 1

Q4.23

arrow
arrow

N/A

0.33
vs 0.33

Q1.24

arrow
arrow

-92%

0.03
vs 0.39

Q2.24

arrow
arrow

-11%

0.51
vs 0.57

Q3.24

arrow
arrow

-10%

0.56
vs 0.62

Q4.24

arrow
arrow

+76%

0.58
vs 0.33

Q1.25

arrow
arrow

+942%

0.31
vs 0.03

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-4%

297.7M  vs 311M

Q1.23

arrow
arrow

-9%

290.6M  vs 318.8M

Q2.23

arrow
arrow

-10%

299M  vs 331.4M

Q3.23

arrow
arrow

-14%

298.7M  vs 348.1M

Q4.23

arrow
arrow

-13%

258.8M  vs 297.7M

Q1.24

arrow
arrow

-15%

246.2M  vs 290.6M

Q2.24

arrow
arrow

-7%

276.8M  vs 299M

Q3.24

arrow
arrow

-5%

282.4M  vs 298.7M

Q4.24

arrow
arrow

+16%

299.6M  vs 258.8M

Q1.25

arrow
arrow

+10%

270.3M  vs 246.2M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-3%

-0.03
vs 0.01

Q1.23

arrow
arrow

-1%

-0.01
vs -0.03

Q2.23

arrow
arrow

+0%

0
vs -0.01

Q3.23

arrow
arrow

+0%

0
vs 0

Q4.23

arrow
arrow

-1%

-0.01
vs 0

Q1.24

arrow
arrow

-1%

-0.01
vs -0.01

Q2.24

arrow
arrow

+0%

0
vs -0.01

Q3.24

arrow
arrow

+1%

0.01
vs 0

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

334

334
vs 377

-11%

Q1.23

arrow
arrow

324

324
vs 334

-3%

Q2.23

arrow
arrow

314

314
vs 324

-3%

Q3.23

arrow
arrow

318

318
vs 314

1%

Q4.23

arrow
arrow

294

294
vs 318

-8%

Q1.24

arrow
arrow

275

275
vs 294

-6%

Q2.24

arrow
arrow

244

244
vs 275

-11%

Q3.24

arrow
arrow

260

260
vs 244

7%

Earnings Growth

Latest News